Minimally	O
invasive	O
percutaneous	B:C0162428
nephrolithotomy	I:C0162428
improves	O
stone	O
-	O
free	O
rates	O
for	O
impacted	O
proximal	O
ureteral	O
stones	I:C0041952
:	O
A	O
systematic	O
review	I:C1955832
and	O
meta-analysis	O
.	O

Minimally	O
invasive	O
percutaneous	O
nephrolithotomy	I:C0162428
improves	O
stone	O
-	O
free	O
rates	O
for	O
impacted	O
proximal	B:C0205107
ureteral	O
stones	I:C0041952
:	O
A	O
systematic	O
review	I:C1955832
and	O
meta-analysis	O
.	O

Minimally	O
invasive	O
percutaneous	O
nephrolithotomy	I:C0162428
improves	O
stone	O
-	O
free	O
rates	O
for	O
impacted	O
proximal	O
ureteral	B:C0041952
stones	I:C0041952
:	O
A	O
systematic	O
review	I:C1955832
and	O
meta-analysis	O
.	O

Minimally	O
invasive	O
percutaneous	O
nephrolithotomy	I:C0162428
improves	O
stone	O
-	O
free	O
rates	O
for	O
impacted	O
proximal	O
ureteral	O
stones	I:C0041952
:	O
A	O
systematic	B:C1955832
review	I:C1955832
and	O
meta-analysis	O
.	O

Minimally	O
invasive	O
percutaneous	O
nephrolithotomy	I:C0162428
improves	O
stone	O
-	O
free	O
rates	O
for	O
impacted	O
proximal	O
ureteral	O
stones	I:C0041952
:	O
A	O
systematic	O
review	I:C1955832
and	O
meta-analysis	B:C0920317
.	O

Urinary	B:C0451641
stones	I:C0451641
are	O
common	O
medical	O
disorders	O
and	O
the	O
treatment	O
of	O
impacted	O
proximal	I:C0041952
ureteral	I:C0041952
stones	I:C0041952
(	O
impacted	O
proximal	I:C0041952
ureteral	I:C0041952
stones	I:C0041952
)	O
is	O
still	O
a	O
challenge	O
for	O
urologists	O
.	O

Urinary	O
stones	I:C0451641
are	O
common	O
medical	O
disorders	B:C0012634
and	O
the	O
treatment	O
of	O
impacted	O
proximal	I:C0041952
ureteral	I:C0041952
stones	I:C0041952
(	O
impacted	O
proximal	I:C0041952
ureteral	I:C0041952
stones	I:C0041952
)	O
is	O
still	O
a	O
challenge	O
for	O
urologists	O
.	O

Urinary	O
stones	I:C0451641
are	O
common	O
medical	O
disorders	O
and	O
the	O
treatment	O
of	O
impacted	B:C0041952
proximal	I:C0041952
ureteral	I:C0041952
stones	I:C0041952
(	O
impacted	O
proximal	I:C0041952
ureteral	I:C0041952
stones	I:C0041952
)	O
is	O
still	O
a	O
challenge	O
for	O
urologists	O
.	O

Urinary	O
stones	I:C0451641
are	O
common	O
medical	O
disorders	O
and	O
the	O
treatment	O
of	O
impacted	O
proximal	I:C0041952
ureteral	I:C0041952
stones	I:C0041952
(	O
impacted	B:C0041952
proximal	I:C0041952
ureteral	I:C0041952
stones	I:C0041952
)	O
is	O
still	O
a	O
challenge	O
for	O
urologists	O
.	O

Urinary	O
stones	I:C0451641
are	O
common	O
medical	O
disorders	O
and	O
the	O
treatment	O
of	O
impacted	O
proximal	I:C0041952
ureteral	I:C0041952
stones	I:C0041952
(	O
impacted	O
proximal	I:C0041952
ureteral	I:C0041952
stones	I:C0041952
)	O
is	O
still	O
a	O
challenge	O
for	O
urologists	B:C0260314
.	O

The	O
aim	O
of	O
this	O
study	B:C2603343
was	O
to	O
compare	O
the	I:C1707887
efficacy	I:C1707887
and	O
safety	O
of	O
minimally	O
invasive	O
percutaneous	O
nephrolithotomy	I:C0162428
(	O
MI	O
-	O
PCNL	O
)	O
and	O
ureteroscopic	O
lithotripsy	I:C0558630
(	O
ureteroscopic	O
lithotripsy	I:C0558630
)	O
in	O
the	O
treatment	O
of	O
impacted	O
proximal	I:C0041952
ureteral	I:C0041952
stones	I:C0041952
via	O
a	O
meta-	O
analysis	I:C0920317
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
compare	B:C1707887
the	I:C1707887
efficacy	I:C1707887
and	O
safety	O
of	O
minimally	O
invasive	O
percutaneous	O
nephrolithotomy	I:C0162428
(	O
MI	O
-	O
PCNL	O
)	O
and	O
ureteroscopic	O
lithotripsy	I:C0558630
(	O
ureteroscopic	O
lithotripsy	I:C0558630
)	O
in	O
the	O
treatment	O
of	O
impacted	O
proximal	I:C0041952
ureteral	I:C0041952
stones	I:C0041952
via	O
a	O
meta-	O
analysis	I:C0920317
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
compare	O
the	I:C1707887
efficacy	I:C1707887
and	O
safety	B:C1705187
of	O
minimally	O
invasive	O
percutaneous	O
nephrolithotomy	I:C0162428
(	O
MI	O
-	O
PCNL	O
)	O
and	O
ureteroscopic	O
lithotripsy	I:C0558630
(	O
ureteroscopic	O
lithotripsy	I:C0558630
)	O
in	O
the	O
treatment	O
of	O
impacted	O
proximal	I:C0041952
ureteral	I:C0041952
stones	I:C0041952
via	O
a	O
meta-	O
analysis	I:C0920317
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
compare	O
the	I:C1707887
efficacy	I:C1707887
and	O
safety	O
of	O
minimally	O
invasive	O
percutaneous	B:C0162428
nephrolithotomy	I:C0162428
(	O
MI	O
-	O
PCNL	O
)	O
and	O
ureteroscopic	O
lithotripsy	I:C0558630
(	O
ureteroscopic	O
lithotripsy	I:C0558630
)	O
in	O
the	O
treatment	O
of	O
impacted	O
proximal	I:C0041952
ureteral	I:C0041952
stones	I:C0041952
via	O
a	O
meta-	O
analysis	I:C0920317
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
compare	O
the	I:C1707887
efficacy	I:C1707887
and	O
safety	O
of	O
minimally	O
invasive	O
percutaneous	O
nephrolithotomy	I:C0162428
(	O
MI	O
-	O
PCNL	B:C0162428
)	O
and	O
ureteroscopic	O
lithotripsy	I:C0558630
(	O
ureteroscopic	O
lithotripsy	I:C0558630
)	O
in	O
the	O
treatment	O
of	O
impacted	O
proximal	I:C0041952
ureteral	I:C0041952
stones	I:C0041952
via	O
a	O
meta-	O
analysis	I:C0920317
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
compare	O
the	I:C1707887
efficacy	I:C1707887
and	O
safety	O
of	O
minimally	O
invasive	O
percutaneous	O
nephrolithotomy	I:C0162428
(	O
MI	O
-	O
PCNL	O
)	O
and	O
ureteroscopic	B:C0558630
lithotripsy	I:C0558630
(	O
ureteroscopic	O
lithotripsy	I:C0558630
)	O
in	O
the	O
treatment	O
of	O
impacted	O
proximal	I:C0041952
ureteral	I:C0041952
stones	I:C0041952
via	O
a	O
meta-	O
analysis	I:C0920317
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
compare	O
the	I:C1707887
efficacy	I:C1707887
and	O
safety	O
of	O
minimally	O
invasive	O
percutaneous	O
nephrolithotomy	I:C0162428
(	O
MI	O
-	O
PCNL	O
)	O
and	O
ureteroscopic	O
lithotripsy	I:C0558630
(	O
ureteroscopic	B:C0558630
lithotripsy	I:C0558630
)	O
in	O
the	O
treatment	O
of	O
impacted	O
proximal	I:C0041952
ureteral	I:C0041952
stones	I:C0041952
via	O
a	O
meta-	O
analysis	I:C0920317
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
compare	O
the	I:C1707887
efficacy	I:C1707887
and	O
safety	O
of	O
minimally	O
invasive	O
percutaneous	O
nephrolithotomy	I:C0162428
(	O
MI	O
-	O
PCNL	O
)	O
and	O
ureteroscopic	O
lithotripsy	I:C0558630
(	O
ureteroscopic	O
lithotripsy	I:C0558630
)	O
in	O
the	O
treatment	O
of	O
impacted	B:C0041952
proximal	I:C0041952
ureteral	I:C0041952
stones	I:C0041952
via	O
a	O
meta-	O
analysis	I:C0920317
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
compare	O
the	I:C1707887
efficacy	I:C1707887
and	O
safety	O
of	O
minimally	O
invasive	O
percutaneous	O
nephrolithotomy	I:C0162428
(	O
MI	O
-	O
PCNL	O
)	O
and	O
ureteroscopic	O
lithotripsy	I:C0558630
(	O
ureteroscopic	O
lithotripsy	I:C0558630
)	O
in	O
the	O
treatment	O
of	O
impacted	O
proximal	I:C0041952
ureteral	I:C0041952
stones	I:C0041952
via	O
a	O
meta-	B:C0920317
analysis	I:C0920317
.	O

We	O
collected	O
studies	B:C0008972
using	O
PubMed	O
,	O
Embase	O
,	O
and	O
Cochrane	O
Library	I:C0242356
from	O
1978	O
to	O
November	O
2016	O
and	O
analyzed	O
them	O
using	O
Stata	O
12.0	I:C0037589
and	O
RevMan	O
5.3	I:C0037589
.	O

We	O
collected	O
studies	O
using	O
PubMed	B:C1138432
,	O
Embase	O
,	O
and	O
Cochrane	O
Library	I:C0242356
from	O
1978	O
to	O
November	O
2016	O
and	O
analyzed	O
them	O
using	O
Stata	O
12.0	I:C0037589
and	O
RevMan	O
5.3	I:C0037589
.	O

We	O
collected	O
studies	O
using	O
PubMed	O
,	O
Embase	B:C0242356
,	O
and	O
Cochrane	O
Library	I:C0242356
from	O
1978	O
to	O
November	O
2016	O
and	O
analyzed	O
them	O
using	O
Stata	O
12.0	I:C0037589
and	O
RevMan	O
5.3	I:C0037589
.	O

We	O
collected	O
studies	O
using	O
PubMed	O
,	O
Embase	O
,	O
and	O
Cochrane	B:C0242356
Library	I:C0242356
from	O
1978	O
to	O
November	O
2016	O
and	O
analyzed	O
them	O
using	O
Stata	O
12.0	I:C0037589
and	O
RevMan	O
5.3	I:C0037589
.	O

We	O
collected	O
studies	O
using	O
PubMed	O
,	O
Embase	O
,	O
and	O
Cochrane	O
Library	I:C0242356
from	O
1978	O
to	O
November	O
2016	O
and	O
analyzed	B:C0936012
them	O
using	O
Stata	O
12.0	I:C0037589
and	O
RevMan	O
5.3	I:C0037589
.	O

We	O
collected	O
studies	O
using	O
PubMed	O
,	O
Embase	O
,	O
and	O
Cochrane	O
Library	I:C0242356
from	O
1978	O
to	O
November	O
2016	O
and	O
analyzed	O
them	O
using	O
Stata	B:C0037589
12.0	I:C0037589
and	O
RevMan	O
5.3	I:C0037589
.	O

We	O
collected	O
studies	O
using	O
PubMed	O
,	O
Embase	O
,	O
and	O
Cochrane	O
Library	I:C0242356
from	O
1978	O
to	O
November	O
2016	O
and	O
analyzed	O
them	O
using	O
Stata	O
12.0	I:C0037589
and	O
RevMan	B:C0037589
5.3	I:C0037589
.	O

All	O
study	B:C2603343
procedures	O
followed	O
the	O
PRISMA	O
guidelines	I:C0282458
.	O

All	O
study	O
procedures	O
followed	O
the	O
PRISMA	B:C0282458
guidelines	I:C0282458
.	O

Five	O
prospective	B:C0033522
studies	I:C0033522
were	O
included	O
in	O
our	O
meta-	O
analysis	I:C0920317
,	O
with	O
242	O
MI	O
-	O
PCNL	O
and	O
256	O
ureteroscopic	O
lithotripsy	I:C0558630
cases	O
.	O

Five	O
prospective	O
studies	I:C0033522
were	O
included	O
in	O
our	O
meta-	B:C0920317
analysis	I:C0920317
,	O
with	O
242	O
MI	O
-	O
PCNL	O
and	O
256	O
ureteroscopic	O
lithotripsy	I:C0558630
cases	O
.	O

Five	O
prospective	O
studies	I:C0033522
were	O
included	O
in	O
our	O
meta-	O
analysis	I:C0920317
,	O
with	O
242	O
MI	O
-	O
PCNL	B:C0162428
and	O
256	O
ureteroscopic	O
lithotripsy	I:C0558630
cases	O
.	O

Five	O
prospective	O
studies	I:C0033522
were	O
included	O
in	O
our	O
meta-	O
analysis	I:C0920317
,	O
with	O
242	O
MI	O
-	O
PCNL	O
and	O
256	O
ureteroscopic	B:C0558630
lithotripsy	I:C0558630
cases	O
.	O

MI	O
-	O
PCNL	B:C0162428
was	O
associated	O
with	O
a	O
longer	O
postoperative	O
hospital	O
stay	O
than	O
ureteroscopic	O
lithotripsy	I:C0558630
(	O
SMD	O
,	O
3.14	O
;	O
95	O
%	O
CI	O
,	O
1.27	O
to	O
5.55	O
)	O
.	O

MI	O
-	O
PCNL	O
was	O
associated	O
with	O
a	O
longer	O
postoperative	O
hospital	O
stay	O
than	O
ureteroscopic	B:C0558630
lithotripsy	I:C0558630
(	O
SMD	O
,	O
3.14	O
;	O
95	O
%	O
CI	O
,	O
1.27	O
to	O
5.55	O
)	O
.	O

In	O
addition	O
,	O
MI	O
-	O
PCNL	B:C0162428
had	O
higher	O
initial	O
(	O
OR	O
,	O
11.12	O
;	O
95	O
%	O
CI	O
,	O
5.56	O
to	O
22.24	O
)	O
and	O
overall	O
stone	O
-	O
free	O
rates	O
(	O
OR	O
,	O
8.70	O
;	O
95	O
%	O
CI	O
,	O
3.23	O
to	O
23.45	O
)	O
than	O
ureteroscopic	O
lithotripsy	I:C0558630
,	O
along	O
with	O
lower	O
possibilities	O
of	O
surgical	O
conversion	I:C3494226
(	O
OR	O
,	O
0.11	O
;	O
95	O
%	O
CI	O
,	O
0.03	O
to	O
0.49	O
)	O
and	O
postoperative	O
shock	O
wave	I:C0015359
lithotripsy	I:C0015359
(	O
OR	O
,	O
0.06	O
;	O
95	O
%	O
CI	O
,	O
0.02	O
to	O
0.18	O
)	O
.	O

In	O
addition	O
,	O
MI	O
-	O
PCNL	O
had	O
higher	O
initial	O
(	O
OR	O
,	O
11.12	O
;	O
95	O
%	O
CI	O
,	O
5.56	O
to	O
22.24	O
)	O
and	O
overall	O
stone	O
-	O
free	O
rates	O
(	O
OR	O
,	O
8.70	O
;	O
95	O
%	O
CI	O
,	O
3.23	O
to	O
23.45	O
)	O
than	O
ureteroscopic	B:C0558630
lithotripsy	I:C0558630
,	O
along	O
with	O
lower	O
possibilities	O
of	O
surgical	O
conversion	I:C3494226
(	O
OR	O
,	O
0.11	O
;	O
95	O
%	O
CI	O
,	O
0.03	O
to	O
0.49	O
)	O
and	O
postoperative	O
shock	O
wave	I:C0015359
lithotripsy	I:C0015359
(	O
OR	O
,	O
0.06	O
;	O
95	O
%	O
CI	O
,	O
0.02	O
to	O
0.18	O
)	O
.	O

In	O
addition	O
,	O
MI	O
-	O
PCNL	O
had	O
higher	O
initial	O
(	O
OR	O
,	O
11.12	O
;	O
95	O
%	O
CI	O
,	O
5.56	O
to	O
22.24	O
)	O
and	O
overall	O
stone	O
-	O
free	O
rates	O
(	O
OR	O
,	O
8.70	O
;	O
95	O
%	O
CI	O
,	O
3.23	O
to	O
23.45	O
)	O
than	O
ureteroscopic	O
lithotripsy	I:C0558630
,	O
along	O
with	O
lower	O
possibilities	O
of	O
surgical	B:C3494226
conversion	I:C3494226
(	O
OR	O
,	O
0.11	O
;	O
95	O
%	O
CI	O
,	O
0.03	O
to	O
0.49	O
)	O
and	O
postoperative	O
shock	O
wave	I:C0015359
lithotripsy	I:C0015359
(	O
OR	O
,	O
0.06	O
;	O
95	O
%	O
CI	O
,	O
0.02	O
to	O
0.18	O
)	O
.	O

In	O
addition	O
,	O
MI	O
-	O
PCNL	O
had	O
higher	O
initial	O
(	O
OR	O
,	O
11.12	O
;	O
95	O
%	O
CI	O
,	O
5.56	O
to	O
22.24	O
)	O
and	O
overall	O
stone	O
-	O
free	O
rates	O
(	O
OR	O
,	O
8.70	O
;	O
95	O
%	O
CI	O
,	O
3.23	O
to	O
23.45	O
)	O
than	O
ureteroscopic	O
lithotripsy	I:C0558630
,	O
along	O
with	O
lower	O
possibilities	O
of	O
surgical	O
conversion	I:C3494226
(	O
OR	O
,	O
0.11	O
;	O
95	O
%	O
CI	O
,	O
0.03	O
to	O
0.49	O
)	O
and	O
postoperative	O
shock	B:C0015359
wave	I:C0015359
lithotripsy	I:C0015359
(	O
OR	O
,	O
0.06	O
;	O
95	O
%	O
CI	O
,	O
0.02	O
to	O
0.18	O
)	O
.	O

Regarding	O
complications	B:C0009566
,	O
no	O
significant	O
differences	O
were	O
observed	O
between	O
MI	O
-	O
PCNL	O
and	O
ureteroscopic	O
lithotripsy	I:C0558630
(	O
OR	O
,	O
1.39	O
;	O
95	O
%	O
CI	O
,	O
0.93	O
to	O
2.10	O
)	O
,	O
except	O
for	O
hematuria	O
(	O
OR	O
,	O
4.80	O
;	O
95	O
%	O
CI	O
,	O
1.45	O
to	O
15.94	O
)	O
.	O

Regarding	O
complications	O
,	O
no	O
significant	O
differences	O
were	O
observed	O
between	B:C0205103
MI	O
-	O
PCNL	O
and	O
ureteroscopic	O
lithotripsy	I:C0558630
(	O
OR	O
,	O
1.39	O
;	O
95	O
%	O
CI	O
,	O
0.93	O
to	O
2.10	O
)	O
,	O
except	O
for	O
hematuria	O
(	O
OR	O
,	O
4.80	O
;	O
95	O
%	O
CI	O
,	O
1.45	O
to	O
15.94	O
)	O
.	O

Regarding	O
complications	O
,	O
no	O
significant	O
differences	O
were	O
observed	O
between	O
MI	O
-	O
PCNL	B:C0162428
and	O
ureteroscopic	O
lithotripsy	I:C0558630
(	O
OR	O
,	O
1.39	O
;	O
95	O
%	O
CI	O
,	O
0.93	O
to	O
2.10	O
)	O
,	O
except	O
for	O
hematuria	O
(	O
OR	O
,	O
4.80	O
;	O
95	O
%	O
CI	O
,	O
1.45	O
to	O
15.94	O
)	O
.	O

Regarding	O
complications	O
,	O
no	O
significant	O
differences	O
were	O
observed	O
between	O
MI	O
-	O
PCNL	O
and	O
ureteroscopic	B:C0558630
lithotripsy	I:C0558630
(	O
OR	O
,	O
1.39	O
;	O
95	O
%	O
CI	O
,	O
0.93	O
to	O
2.10	O
)	O
,	O
except	O
for	O
hematuria	O
(	O
OR	O
,	O
4.80	O
;	O
95	O
%	O
CI	O
,	O
1.45	O
to	O
15.94	O
)	O
.	O

Regarding	O
complications	O
,	O
no	O
significant	O
differences	O
were	O
observed	O
between	O
MI	O
-	O
PCNL	O
and	O
ureteroscopic	O
lithotripsy	I:C0558630
(	O
OR	O
,	O
1.39	O
;	O
95	O
%	O
CI	O
,	O
0.93	O
to	O
2.10	O
)	O
,	O
except	O
for	O
hematuria	B:C0018965
(	O
OR	O
,	O
4.80	O
;	O
95	O
%	O
CI	O
,	O
1.45	O
to	O
15.94	O
)	O
.	O

MI	O
-	O
PCNL	B:C0162428
is	O
optimal	O
and	O
should	O
be	O
considered	O
as	O
the	O
preferred	O
treatment	O
method	I:C0087111
for	O
impacted	O
proximal	I:C0041952
ureteral	I:C0041952
stones	I:C0041952
,	O
as	O
it	O
has	O
better	O
efficacy	O
and	O
a	O
safety	O
profile	O
similar	O
to	O
that	O
of	O
ureteroscopic	O
lithotripsy	I:C0558630
.	O

MI	O
-	O
PCNL	O
is	O
optimal	O
and	O
should	O
be	O
considered	O
as	O
the	O
preferred	O
treatment	B:C0087111
method	I:C0087111
for	O
impacted	O
proximal	I:C0041952
ureteral	I:C0041952
stones	I:C0041952
,	O
as	O
it	O
has	O
better	O
efficacy	O
and	O
a	O
safety	O
profile	O
similar	O
to	O
that	O
of	O
ureteroscopic	O
lithotripsy	I:C0558630
.	O

MI	O
-	O
PCNL	O
is	O
optimal	O
and	O
should	O
be	O
considered	O
as	O
the	O
preferred	O
treatment	O
method	I:C0087111
for	O
impacted	B:C0041952
proximal	I:C0041952
ureteral	I:C0041952
stones	I:C0041952
,	O
as	O
it	O
has	O
better	O
efficacy	O
and	O
a	O
safety	O
profile	O
similar	O
to	O
that	O
of	O
ureteroscopic	O
lithotripsy	I:C0558630
.	O

MI	O
-	O
PCNL	O
is	O
optimal	O
and	O
should	O
be	O
considered	O
as	O
the	O
preferred	O
treatment	O
method	I:C0087111
for	O
impacted	O
proximal	I:C0041952
ureteral	I:C0041952
stones	I:C0041952
,	O
as	O
it	O
has	O
better	O
efficacy	O
and	O
a	O
safety	B:C1705187
profile	O
similar	O
to	O
that	O
of	O
ureteroscopic	O
lithotripsy	I:C0558630
.	O

MI	O
-	O
PCNL	O
is	O
optimal	O
and	O
should	O
be	O
considered	O
as	O
the	O
preferred	O
treatment	O
method	I:C0087111
for	O
impacted	O
proximal	I:C0041952
ureteral	I:C0041952
stones	I:C0041952
,	O
as	O
it	O
has	O
better	O
efficacy	O
and	O
a	O
safety	O
profile	O
similar	O
to	O
that	O
of	O
ureteroscopic	B:C0558630
lithotripsy	I:C0558630
.	O

